Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma
NCT07333430
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory Multiple Myeloma (MM)
Interventions
BIOLOGICAL:
Naive HBI0101 CAR-T
Sponsor
Hadassah Medical Organization